Journal of the Peripheral Nervous System

Article	Citations
	70
	51
Abstracts	38
	28
Broadening Research Priorities in Peripheral Neuropathy: A Response to “A Call to Action for Peripheral Neuropathy Research Funding—Time to Consolidate Funding Under One NIH Initiative?”	26
Safety and Cost Analysis of Immunoglobulin Cessation Trials in Chronic Inflammatory Demyelinating Polyradiculoneuropathy	24
PNS Abstracts 2023	21
Identifying Predictors of Idiopathic Small‐Fiber Neuropathy in Adolescent Patients With Chronic Pain	19
Prospective Evaluation of Machine‐Assisted Electrophysiologic and Online Clinical Diagnostic Support Tools in Chronic Inflammatory Demyelinating Polyradiculoneuropathy	19
Toxic medications in Charcot–Marie–Tooth patients: A systematic review	19
	18
Abstracts of the 33rd annual meeting of the Japanese peripheral nerve society (JPNS)	18
Loss of MEGF10 Decreases the Number of Perisynaptic Schwann Cells and Innervation of Neuromuscular Junctions in Aging Mice	17
Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study	17
Nerve ultrasound as a screening tool for inherited sensory neuronopathy	16
Ofatumumab for treating autoimmune nodopathy	16
Genetic, electrophysiological, and pathological studies on patients with SCN9A‐related pain disorders	16
Corneal confocal microscopy in small and mixed fiber neuropathy—Comparison with skin biopsy and cold detection in a large prospective cohort	15
Variability in Conduction Block Definitions Affects the Sensitivity of Diagnostic Criteria for Multifocal Motor Neuropathy	14
Abstracts of the 35th Annual Meeting of the Japanese Peripheral Nerve Society (JPNS)	14
Issue Information	14
Effectiveness of exercise therapy for individuals diagnosed with Charcot–Marie–Tooth disease: A systematic review of randomized clinical trials	13
Long read sequencing overcomes challenges in the diagnosis of SORD neuropathy	12
Assessing corneal dendritic cells in glucose dysregulation small‐fibre neuropathy	12
Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology	12

Feasibility, Validity, and Reliability of the Virtual CMT Infant Toddler Scale (vCMTInfS): A Remote Evaluation of Infants/Toddlers With CMT	12
Parent‐proxy pediatric CMT quality of life outcome measure: Validation of the Italian version	11
Issue Information	11
Association of dynamic hepatic metabolism with clinical outcomes in patients with severe Guillain‐Barré syndrome: A prospective cohort study from multi‐centers in China	11
Novel Dominant Splicing Variant in MPZ Associated With Unusual Charcot–Marie–Tooth Disease	11
Pain hypersensitivity, sensorimotor impairment, and decreased muscle force in a novel rat model of radiation‐induced peripheral neuropathy	11
Patient‐reported disease burden in the Accelerate Clinical Trials in Charcot–Marie–Tooth Disease Study	10
Disease‐specific wearable sensor algorithms for profiling activity, gait, and balance in individuals with Charcot–Marie–Tooth disease type 1A	10
Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic problems in clinical practice in Serbia	10
Issue Information	10
IgM anti‐MAG± peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M‐protei	10
Peripheral neuropathy as clinical onset of monoclonal IgM/k‐related amyloidosis	10
A Novel Case of Nerve Biopsy Proven Wild Type Transthyretin (TTR) Amyloidosis	10
Diagnostic and clinical utility of comprehensive multigene panel testing for patients with neuropathy	10
Rethinking Neuropathy in TTC19 Mutations: The Need for Broader Differential Diagnosis	9
Peter James Dyck: In Memoriam	9
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision	9
Frequent De Novo Mutations in Korean Patients With Charcot–Marie–Tooth Disease	9
	8
Issue Information	8
	8
Benefit of high‐dose oral riboflavin therapy in riboflavin transporter deficiency	8
Issue Information	8
Intravenous Immunoglobulin Elevates Regulatory T Cells in Guillain‐Barré Syndrome: A Potential Biomarker of Therapeutic Response	7
Glucose‐lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes	7
A novel de novo variant in POLR3B gene associated with a primary axonal involvement of the largest nerve fibers	7
Issue Information	7
Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study (DINE)	6
An innovative phase 2 proof‐of‐concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy	6
	6
Issue Information	6
ABSTRACT	6
Reply to “Nerve ultrasound as a screening tool for inherited sensory neuronopathy”	6
The autoimmune vulnerability of the node of Ranvier	6
Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies	5
Influence of Genomic Ancestry and Other Traditional Risk Factors on the Prevalence of Diabetic Peripheral Neuropathy in Admixed Individuals With Type 1 Diabetes in Brazil: A Pioneer Multicenter Study	5
The small fiber neuropathy—symptom inventory questionnaire (SFN‐SIQ) does not discriminate between patients with or without small fiber neuropathy	5
Impact of High‐Dose Tafamidis on Hereditary ATTR ( ATTRv ) Amyloidosis With Central Nervous System	5
Molecular Characterization of Oxaliplatin‐Induced Peripheral Neurotoxicity: The Complex Spectrum of Painful Manifestations	5
	5
Digenesis in Charcot–Marie–Tooth Disease: Impact of Combined Mutations in the MFN2 and GDAP1 Genes	5
Diagnostic value of nerve conduction study in NOTCH2NLC‐related neuronal intranuclear inclusion disease	5
INF2 mutations in patients with a broad phenotypic spectrum of Charcot‐Marie‐Tooth disease and focal segmental glomerulosclerosis	5
	5
Correction to “Polyneuropathy in Kidney Transplant Recipients: Accuracy of a New Clinical Diagnostic Scoring System”	5
Validation of an Artificial Intelligence driven framework to automatically detect red flag symptoms in screening for rare diseases in electronic health records: hereditary transthyretin amyloidosis po	5
Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin‐related amyloidosis—A Swiss reference center experience	5
Acquired Transthyretin Amyloidosis in Domino Liver Transplantation Treated With Gene‐Silencers	5
Predicting long‐term trends in inflammatory neuropathy outcome measures using latent class modelling	4
Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial	4

Clinical and Electrophysiological Characterization of Diabetic Neuropathy in a Sub‐Saharan African Cohort	4
The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN‐SIQ): Reply to letter to the Editor	4
Anxiety and depression in small fiber neuropathy	4
Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?	4
GDAP1‐Related Charcot–Marie–Tooth Disease: Axonal or Demyelinating Subtype? Autosomal Recessive or Autosomal Dominant Inheritance?	4
Nonsystemic Vasculitic Neuropathy—A Brazilian Case Series	4
Issue Information	4
Genetic and Clinical Features of 10 Families With Hereditary Sensory Neuropathies	4
Issue Information	4
Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study	4
COVID‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era	4
Macrophages influence Schwann cell myelin autophagy after nerve injury and in a model of Charcot‐Marie‐Tooth disease	4
Cutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidis	4
High‐Fat Diet Disrupt Nerve Function by Targeting Schwann Cells	4
	3
Recent advances in the treatment of Charcot‐Marie‐Tooth neuropathies	3
Clinical, histologic, and immunologic signatures of Small Fiber Neuropathy in Systemic Lupus Erythematosus	3
Issue Information	3
Neurological Performance and Clinical Outcomes Related to Patients With Oropouche‐Associated Guillain–Barré Syndrome	3
Etiologic Diagnosis of Neuropathies Based on First‐Line Screening of TTR Gene Mutations	3
Validation of the parent‐proxy version of the pediatric Charcot‐Marie‐Tooth disease quality of life instrument for children aged 0–7 years	3
Focal slowing of nerve conduction velocity in leprosy patients unveiled through multisegmented nerve analysis	3
Earlier diagnosis of peripheral neuropathy in primary care: A call to action	3
Rasch‐Built Overall Disability Scale for IgM‐Associated Polyneuropathy With and Without Anti‐MAG Antibodies: IgM‐RODS	3
Phenotypic features of RETREG1‐related hereditary sensory autonomic neuropathy	3
Genetic diversity in hereditary axonal neuropathy: Analyzing 53 Brazilian children	3
Hyaluronidase‐facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE‐CIDP 1 randomized controlled tria	3
Frequency dependent, reversible focused ultrasound suppression of evoked potentials in the reflex arc in an anesthetized animal	3
The NCX1 calcium exchanger is implicated in delayed axotomy after peripheral nerve stretch injury	3
Issue Information	3
A Case of Retinopathy–Sensory Neuropathy Syndrome With a Novel Compound Heterozygous FLVCR1 Varian	3
Genetic and clinical profile of 15 Chinese families with GDAP1‐related Charcot–Marie–Tooth disease and identification of H256R as a frequent mutation	3
Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review	3
Ultrasound Shear Wave Velocity of Peripheral Nerves: A Possible Non‐Invasive Biomarker for Demyelinating Neuropathies	3
Identical late motor responses in early Guillain‐Barré syndrome: A‐waves and repeater F‐waves	3
Blood 1‐Deoxysphingolipid Levels Are Associated With Epidermal Denervation in Small Fiber Neuropathy	3
Longitudinal Assessment of Quality of Life and Functionality by CAP ‐ PRI in Patients With Active	3
New Approaches Based on Serial‐Block Face Electron Microscopy to Investigate the Peripheral Nervous System	2
Epidemiology, Presentation, Management and Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy in Birmingham, UK : The Impact of Ethnicity	2
Current profile of Charcot‐Marie‐Tooth disease in Africa: A systematic review	2
Plasma proteomic analysis on neuropathic pain in idiopathic peripheral neuropathy patients	2
Initial findings using high‐resolution magnetic resonance imaging for visualisation of the sural nerve and surrounding anatomy in healthy volunteers at 7 Tesla	2
CIDP Treatment Outcomes Correlation With First Nerve Conduction Changes: Ascertainment of Initial and Long‐Term Responders	2
Leptospirosis‐induced acute acquired inflammatory neuropathy	2
Mutational screening of Greek patients with axonal Charcot‐Marie‐Tooth disease using targeted next‐generation sequencing: Clinical and molecular spectrum delineation	2
Altered Cellular Pathways in the Blood of Patients With Guillain‐Barre Syndrome	2
Issue Information	2
Expanding the genetic and clinical spectrum of SORD‐related peripheral neuropathy by reporting a novel variant c.210T>G and evidence of subclinical muscle involvement	2
Description of a patient cohort with Hereditary Sensory Neuropathy type 1 without retinal disease Macular Telangiectasia type 2 ‐ implications for retinal screening in HSN1	2
Advanced Hybrid Closed‐Loop Insulin Delivery Is Associated With Improved Glycemic Indicators and Normalization of Small Nerve Fibre Structure in Adults With Type 1 Diabetes	2
Correction to “The Correlation Between Functional and Morphometric Small Fiber Assessment in Mixed Etiology Polyneuropathy”	2
	2
Abstract	2
Identification of cellular and noncellular components of mature intact human peripheral nerve	2
Differential Impact of Metabolic Factors and Comorbidities on Peripheral Neuropathy	2
Issue Information	2
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity	2
	2
Targeting translation: A review of preclinical animal models in the development of treatments for chemotherapy‐induced peripheral neuropathy	2
Adult‐onset Krabbe disease presenting as isolated sensorimotor demyelinating polyneuropathy: A case report	2
Digital nerve reconstruction with a new composite silk fibroin nerve conduit	2
A call to action for peripheral neuropathy research funding—Time to consolidate funding under one NIH initiative?	2
Unusual upper limb features in SORD neuropathy	2
Validation and Reliability of the Thai Pediatric Charcot–Marie–Tooth Quality of Life Outcome Measure	2
Imbalance and lower limb tremor in chronic inflammatory demyelinating polyradiculoneuropathy: Reply to Letter to the Editor	2
Axolemmal nanoruptures arising from paranodal membrane injury induce secondary axon degeneration in murine Guillain‐Barré syndrome	2
Issue Information	2
Designing and Implementing a Web‐Based Platform for Accurate and Reliable Clinical Outcome Measures and Global Certification for Evaluating Charcot–Marie–Tooth disease	2
Pseudodominant Inheritance of Biallelic RFC1 Expansions—Revisiting the 3p22‐p24	2
Patient‐Reported Outcome Measures for Assessing Health‐Related Quality of Life in Patients With Polyneuropathies, Focusing on Guillain‐Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropa	2
Real‐World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape	1
Peripheral Neuropathy as an Early Marker in Newborn‐Screened Krabbe Disease: The Value of Pre‐Confirmatory Neurophysiological Testing	1
Long‐Term Functional Outcomes in Immunoglobulin‐Treated Multifocal Motor Neuropathy Evaluated Through the MMN ‐Rasch‐Built Overall Disability Scale	1
Plasma neurofilament light chain concentrations are elevated in youth‐onset type 2 diabetes and associated with neuropathy	1
Changes in axonal and clinical function during intravenous and subcutaneous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy	1
Issue Information	1
Correction to “Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study”	1
Minimal invasive biopsies are highly sensitive for amyloid detection in hereditary transthyretin amyloidosis with polyneuropathy	1
Abstract	1
Vitamin D levels do not correlate with severity of idiopathic peripheral neuropathy	1

Motor Neuropathy in a Patient With Mitochondrial Disease and a Novel TTC19 Variant: An Underrecognized Phenotypic Feature	1
Genetic Deletion of Sarm1 in Mouse Models of Three Neurological Diseases	1
	1
Human Cytomegalovirus Associated Neuropathies: A Comprehensive Review From Pathophysiology to Clinical and Therapeutic Considerations	1
Polyneuropathy in Kidney Transplant Recipients: Accuracy of a New Clinical Diagnostic Scoring System	1
Laura Feltri: In memoriam	1
Issue Information	1
Spontaneous activity of specific C‐nociceptor subtypes from diabetic patients and mice: Involvement of reactive dicarbonyl compounds and (sensitized) transient receptor potential channel A1	1
	1
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome	1
Rasch‐built overall disability scale for POEMS syndrome (POEMS‐RODS)	1
A study concept of expeditious clinical enrollment for genetic modifier studies in Charcot–Marie–Tooth neuropathy 1A	1
Intrathecal Antibody Synthesis in Autoimmune Nodopathy	1
Hip Dysplasia in Charcot–Marie–Tooth Disease: Insights From a Large Cohort of Children and Adolescents	1
Prognostic value of neurofilament light in blood in patients with polyneuropathy: A systematic review	1
Somatosensory profiling of patients undergoing alcohol withdrawal: Do neuropathic pain and sensory loss represent a problem?	1
Eculizumab as a Disease‐Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Case Report	1
B‐cell and T‐cell receptor repertoire in chronic inflammatory demyelinating polyneuropathy, a prospective cohort study	1
EGR2 gene‐linked hereditary neuropathies present with a bimodal age distribution at symptoms onset	1
Serum neurofilament light chain measurements following nerve trauma	1
Monoclonal gammopathy‐associated peripheral neuropathies: Uncovering pearls and challenges	1
Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: Potential relevance of antibody titers in monitoring treatment response	1
Sural nerve biopsy utility by masked assessment of individual histologic preparations	1
Feasibility and Reliability of a Monitoring App for Chronic Inflammatory Neuropathies	1
ITPR1 Deletion in a Patient With Sensory Ataxic Neuropathy and Sjögren Syndrome	1
Results From a Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ANX005, a C1q Inhibitor, in Patients With Guillain–Barré Syndrome	1
A 21‐bp deletion in the complement regulator CD55 promotor region is associated with multifocal motor neuropathy and its disease course	1
Issue Information	1
The Easy Handgrip Test as a Tool for Assessing Motor Fatigability in Children With Charcot‐Marie‐Tooth Disease Type 1A	1
Validation of the Korean version of inflammatory Rasch‐built Overall Disability Scale in patients with inflammatory neuropathy	1
Variations within Toll‐like receptor (TLR) and TLR signaling pathway‐related genes and their synergistic effects on the risk of Guillain‐Barré syndrome	1